glucose, (beta-d)-isomer has been researched along with Acetonemia in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 14 (63.64) | 24.3611 |
| 2020's | 7 (31.82) | 2.80 |
| Authors | Studies |
|---|---|
| Cerone, SI; García, MC; Sansinanea, AS | 1 |
| Seki, H; Watanabe, H; Yorozu, T | 1 |
| Cardinez, N; Eldelekli, D; Falappa, CM; Ghanbari, M; Gouchie-Provencher, N; Haidar, A; Jafar, A; Lovblom, LE; Orszag, A; Perkins, BA; Rutkowski, J; Tsoukas, MA; Yale, JF | 1 |
| Fu, Z; Husain, M; Ilkayeva, O; Inzucchi, SE; Javaheri, A; Jones, P; Kosiborod, MN; Kwee, LC; Lanfear, DE; Margulies, KB; McGuire, DK; Mentz, RJ; Nassif, ME; Newgard, CB; Pitt, B; Scirica, BM; Selvaraj, S; Shah, SH; Windsor, SL | 1 |
| Iizuka, K; Kato, T; Liu, Y; Mizuno, M; Nonomura, K; Takao, K; Yabe, D; Yasuda, M | 1 |
| Fourlanos, S; Neoh, SL; Nolan, BJ; Varadarajan, S | 1 |
| Bolli, GB; Fanelli, CG; Lucidi, P; Porcellati, F | 1 |
| Davies, M; Fielding, BA; Garesse, R; Herring, RA; Jackson, N; Johnsen, S; Mendis, A; Russell-Jones, DL; Shojaee-Moradie, F; Stevenage, M; Umpleby, AM | 1 |
| Fukagawa, M; Miyauchi, M; Toyoda, M | 1 |
| Breuer, TGK; Kampmann, K; Meier, JJ; Schmidt, WE; Steinfort, C; Uhl, W; Wutzler, A | 1 |
| Baek, SI; Choi, SH; Jang, HC; Kim, KM; Lee, DH; Lim, S; Min, SH; Moon, JH; Oh, TJ; Park, KS | 1 |
| Chan, MJ; Hsu, CW; Huang, WH; Weng, CH; Yen, TH | 1 |
| Chua, CL; Lim, GJ; Low, SKM; Shao, Y; Sum, CF; Wong, YF; Yeoh, ECK | 1 |
| Inzucchi, SE; Lupsa, BC | 1 |
| Han, S; Jin, K; Paek, JH; Park, H; Park, SB; Park, WY; Yeo, SM | 1 |
| Cardone, RL; Kibbey, RG; Perry, RJ; Rabin-Court, A; Shulman, GI; Song, JD; Wang, Y | 1 |
| Aharon-Hananel, G; Raz, I | 1 |
| Araki, E; Iwamoto, Y; Kaku, K; Suganami, H; Tanizawa, Y; Terauchi, Y; Tobe, K; Ueda, M; Utsunomiya, K; Watada, H; Watanabe, D | 1 |
| Ghosh, A; Gupta, R; Misra, A | 1 |
| Faillie, JL | 1 |
| Scheen, AJ | 1 |
3 review(s) available for glucose, (beta-d)-isomer and Acetonemia
| Article | Year |
|---|---|
Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits.
Topics: Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Bone and Bones; Canagliflozin; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Glucosides; Humans; Hypoglycemic Agents; Ketosis; Kidney; Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Weight Loss | 2018 |
Pharmacological aspects of the safety of gliflozins.
Topics: Animals; Benzhydryl Compounds; Fractures, Bone; Glomerular Filtration Rate; Glucosides; Humans; Hypoglycemic Agents; Ketosis; Lipids; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2 Inhibitors | 2017 |
SGLT2 Inhibitors: Benefit/Risk Balance.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Fractures, Bone; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Ketosis; Risk Assessment; Sodium-Glucose Transporter 2 Inhibitors | 2016 |
2 trial(s) available for glucose, (beta-d)-isomer and Acetonemia
| Article | Year |
|---|---|
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial.
Topics: Adult; Benzhydryl Compounds; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 1; Glucosides; Humans; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Ketosis; Treatment Outcome | 2022 |
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative
Topics: Adult; Aged; Asian People; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glucosides; Humans; Hypoglycemic Agents; Ketosis; Male; Middle Aged; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Young Adult | 2014 |
17 other study(ies) available for glucose, (beta-d)-isomer and Acetonemia
| Article | Year |
|---|---|
Effects of beta-hydroxybutyric acid on bovine milk leukocytes function in vitro.
Topics: 3-Hydroxybutyric Acid; Animals; Cattle; Female; Hydrogen Peroxide; Ketone Bodies; Ketosis; Leukocytes; Macrophages; Milk; Neutrophils; Nitroblue Tetrazolium; Phagocytosis; Tetradecanoylphorbol Acetate; Zymosan | 2007 |
Postoperative Ketoacidosis With Hypoglycemia in a Nondiabetic Patient Taking Dapagliflozin for Heart Failure: A Case Report.
Topics: Aged, 80 and over; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Heart Failure; Humans; Hypoglycemia; Ketosis | 2022 |
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF.
Topics: Aged; Benzhydryl Compounds; Biomarkers; Cardiomyopathies; Fatty Acids; Female; Glucosides; Heart Failure; Humans; Ketones; Ketosis; Male; Middle Aged; Quality of Life; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Ventricular Dysfunction, Left | 2022 |
Sodium-glucose cotransporter 2 inhibitor and sarcopenia in a lean elderly adult with type 2 diabetes: A case report.
Topics: Aged; Benzhydryl Compounds; Body Weight; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Ketosis; Sarcopenia; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Beware Ketoacidosis with SGLT2 Inhibitors in Latent Autoimmune Diabetes of the Adult.
Topics: Aged; Autoantibodies; Benzhydryl Compounds; Diabetic Ketoacidosis; Female; Fluid Therapy; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Ketosis; Latent Autoimmune Diabetes in Adults; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 1; Glucosides; Humans; Insulin; Ketosis; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Response to Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 1; Glucosides; Humans; Insulin; Ketosis; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Atypical Ketoacidosis and Protracted Hyperglycosuria after Treatment with Ipragliflozin, an SGLT2 Inhibitor.
Topics: Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Ketosis; Obesity; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Young Adult | 2017 |
[Severe atypical ketoacidosis due to SGLT2-inhibitor therapy : Two case reports].
Topics: Benzhydryl Compounds; Blood Glucose; Critical Care; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fluid Therapy; Glucosides; Humans; Ketosis; Sodium-Glucose Transporter 2 Inhibitors | 2018 |
Degree of ketonaemia and its association with insulin resistance after dapagliflozin treatment in type 2 diabetes.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adult; Aged; Benzhydryl Compounds; Case-Control Studies; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypoglycemic Agents; Insulin Resistance; Ketosis; Middle Aged; Young Adult | 2018 |
Dapagliflozin associated ketoacidosis: A must know fact for nephrologists.
Topics: Benzhydryl Compounds; Biomarkers; Blood Glucose; Diabetes Mellitus; Female; Glucosides; Humans; Ketosis; Middle Aged; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors | 2018 |
The effect of Ramadan fasting and continuing sodium-glucose co-transporter-2 (SGLT2) inhibitor use on ketonemia, blood pressure and renal function in Muslim patients with type 2 diabetes.
Topics: Adult; Aged; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Canagliflozin; Diabetes Mellitus, Type 2; Fasting; Female; Glomerular Filtration Rate; Glucosides; Humans; Hypoglycemic Agents; Islam; Ketosis; Kidney; Male; Middle Aged; Prospective Studies; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Young Adult | 2018 |
Ketoacidosis with euglycemia in a patient with type 2 diabetes mellitus taking dapagliflozin: A case report.
Topics: Adult; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Insulin; Ketosis; Renal Replacement Therapy; Saline Solution; Sodium Bicarbonate; Young Adult | 2019 |
Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats.
Topics: Animals; Benzhydryl Compounds; Dehydration; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucocorticoids; Glucose; Glucosides; Humans; Insulin; Ketosis; Lipolysis; Liver; Male; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
An evaluation of the efficacy and safety of Tofogliflozin for the treatment of type II diabetes.
Topics: Benzhydryl Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Glucosides; Glycated Hemoglobin; Half-Life; Humans; Hypoglycemia; Ketosis; Kidney Diseases; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2019 |
In brief: ketoacidosis with SGLT2 inhibitors.
Topics: Benzhydryl Compounds; Canagliflozin; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypoglycemic Agents; Ketosis; Sodium-Glucose Transporter 2 Inhibitors | 2015 |
Ketonuria/ketonemia associated with the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors in type 2 diabetes: A report of three cases from New Delhi, India.
Topics: Benzhydryl Compounds; Blood Glucose; Canagliflozin; Diabetes Mellitus, Type 2; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; India; Ketosis; Male; Middle Aged; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2016 |